274 related articles for article (PubMed ID: 23836691)
1. Action potential wavelength restitution predicts alternans and arrhythmia in murine Scn5a(+/-) hearts.
Matthews GD; Guzadhur L; Sabir IN; Grace AA; Huang CL
J Physiol; 2013 Sep; 591(17):4167-88. PubMed ID: 23836691
[TBL] [Abstract][Full Text] [Related]
2. Nonlinearity between action potential alternans and restitution, which both predict ventricular arrhythmic properties in Scn5a+/- and wild-type murine hearts.
Matthews GD; Guzadhur L; Grace A; Huang CL
J Appl Physiol (1985); 2012 Jun; 112(11):1847-63. PubMed ID: 22461438
[TBL] [Abstract][Full Text] [Related]
3. Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.
Martin CA; Grace AA; Huang CL
Pflugers Arch; 2011 Oct; 462(4):495-504. PubMed ID: 21779762
[TBL] [Abstract][Full Text] [Related]
4. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
Stokoe KS; Thomas G; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):69-84. PubMed ID: 17023504
[TBL] [Abstract][Full Text] [Related]
5. Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model.
Martin CA; Grace AA; Huang CL
Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H605-16. PubMed ID: 21097662
[TBL] [Abstract][Full Text] [Related]
6. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
[TBL] [Abstract][Full Text] [Related]
7. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.
Sabir IN; Li LM; Jones VJ; Goddard CA; Grace AA; Huang CL
Pflugers Arch; 2008 Jan; 455(4):637-51. PubMed ID: 17805561
[TBL] [Abstract][Full Text] [Related]
8. Regional variations in action potential alternans in isolated murine Scn5a (+/-) hearts during dynamic pacing.
Matthews GD; Martin CA; Grace AA; Zhang Y; Huang CL
Acta Physiol (Oxf); 2010 Oct; 200(2):129-46. PubMed ID: 20384594
[TBL] [Abstract][Full Text] [Related]
9. Effects of flecainide and quinidine on action potential and ventricular arrhythmogenic properties in Scn3b knockout mice.
Hakim P; Thresher R; Grace AA; Huang CL
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):782-9. PubMed ID: 20132234
[TBL] [Abstract][Full Text] [Related]
10. Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Dautova Y; Zhang Y; Grace AA; Huang CL
Exp Physiol; 2010 Oct; 95(10):994-1007. PubMed ID: 20621962
[TBL] [Abstract][Full Text] [Related]
11. Increased right ventricular repolarization gradients promote arrhythmogenesis in a murine model of Brugada syndrome.
Martin CA; Zhang Y; Grace AA; Huang CL
J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1153-9. PubMed ID: 20384647
[TBL] [Abstract][Full Text] [Related]
12. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease.
Derangeon M; Montnach J; Cerpa CO; Jagu B; Patin J; Toumaniantz G; Girardeau A; Huang CLH; Colledge WH; Grace AA; Baró I; Charpentier F
Cardiovasc Res; 2017 Apr; 113(5):464-474. PubMed ID: 28339646
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
Hothi SS; Booth SW; Sabir IN; Killeen MJ; Simpson F; Zhang Y; Grace AA; Huang CL
Prog Biophys Mol Biol; 2008; 98(2-3):267-80. PubMed ID: 19351517
[TBL] [Abstract][Full Text] [Related]
15. The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles.
Ning F; Luo L; Ahmad S; Valli H; Jeevaratnam K; Wang T; Guzadhur L; Yang D; Fraser JA; Huang CL; Ma A; Salvage SC
Pflugers Arch; 2016 Apr; 468(4):655-65. PubMed ID: 26545784
[TBL] [Abstract][Full Text] [Related]
16. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model.
Martin CA; Guzadhur L; Grace AA; Lei M; Huang CL
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1853-62. PubMed ID: 21378142
[TBL] [Abstract][Full Text] [Related]
17. Reduced Na(+) and higher K(+) channel expression and function contribute to right ventricular origin of arrhythmias in Scn5a+/- mice.
Martin CA; Siedlecka U; Kemmerich K; Lawrence J; Cartledge J; Guzadhur L; Brice N; Grace AA; Schwiening C; Terracciano CM; Huang CL
Open Biol; 2012 Jun; 2(6):120072. PubMed ID: 22773948
[TBL] [Abstract][Full Text] [Related]
18. Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.
Dautova Y; Zhang Y; Sabir I; Grace AA; Huang CL
Pflugers Arch; 2009 Jul; 458(3):443-57. PubMed ID: 19184093
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
Osadchii OE
PLoS One; 2018; 13(1):e0191514. PubMed ID: 29352276
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S
Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]